Skip to content

Hearing preservation in cochlear implantation surgery

Hearing preservation in cochlear implantation surgery - Hearing preservation in cochlear implantation surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49726
Enrollment
48
Registered
2019-10-18
Start date
2020-01-29
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deafness sensory neuronal hearing loss

Interventions

Randomisation to one of the four groups.

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Severe hearing loss, CI candidate - 18 years of age or older - normal function of middle ear (i.e. no acute middle ear infections) - dutch language proficiency - choice for Advanced Bionics implant

Exclusion criteria

Exclusion criteria: - prior otologic surgery in the implanted ear (excluding tympanostomy tube placement) - inner ear malformation present in the ear to be implanted (i.e. ossification, Mondini malformation) - retrocochlear pathology present in the auditory system to be implanted - neurocognitive disorders - sudden deafness

Design outcomes

Primary

MeasureTime frame
Hearing preservation is the main outcome, which will be expressed in percentage. Hearing preservation is calculated by using the preoperative and postoperative puretoneaudiometry (PTA).

Secondary

MeasureTime frame
Scalar position of the electrode array (scala tympani or scala vestibuli assessed by CB-CT), ECochG (among others amplitude in µV) and eCAP (among others amplitude in µV) potentials, and speech perception test with/without noise in CVC words correct score (in percentage) with signal to noise ratio of 10 dB.

Countries

Netherlands

Contacts

Public ContactIAML Beurden

Universitair Medisch Centrum Utrecht

kno@umcutrecht.nl+31 88 75 566 44

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)